B + L’s Victus femtosecond laser cleared by FDA

Have you gotten a chance to read the August 8th issue of the Ophthalmology Times eReport? In this e-newsletter we released information on the Victus femtosecond laser receiving FDA approval, separate and combined cataract surgery, a protein that may block diabetic retinopathy damage (atypical protein kinase C), and more. Check out the articles in this issue below.

And please follow us on Twitter and Facebook

Femtosecond laser cleared by FDA

Bausch + Lomb (B + L) and Technolas Perfect Vision GmbH (TPV) have received 510(k) clearance from the FDA for a femtosecond laser platform (Victus), and it is now available for shipment within the United States. Read more

Combined or separate cataract, DSAEK procedures in Fuchs’ dystrophy?

In patients who present with both cataract and Fuchs’ endothelial corneal dystrophy, ophthalmologists have the option of performing cataract extraction alone or simultaneously with Descemet’s stripping automated endothelial keratoplasty (DSAEK), said Anthony Aldave, MD, at the 29th annual Current Concepts in Ophthalmology conference. Careful patient selection and informed consent are vital to choosing the proper approach. Read more

Cataract surgery reduces hip fracture risk

Patients who had cataract removal surgery were found to have a 16% decrease in the risk of hip fracture compared with patients who did not undergo the procedure, according to an observational study of more than 400,000 Medicare beneficiaries. Read more

Protein may block diabetic retinopathy damage

A protein that could “interrupt” the chain of events that causes retinal damage in diabetic retinopathy has been identified by researchers at the University of Michigan Kellogg Eye Center. The finding could lead to a therapy that targets two mechanisms at the root of the disease: inflammation and the weakening of the blood barrier that protects the retina. Read more

Jason Woody honored by EBAA

Jason Woody, president and chief executive officer of the Lions Eye Institute for Transplant & Research (LEITR), has received the Leonard Heise Award from the Eye Bank Association of America (EBAA). Read more

Prevent Blindness America Swing Fore Sight Golf Tournament supports eye programs

Sight-saving programs of Prevent Blindness America (PBA) will be supported by the 5th Annual Swing Fore Sight Golf Tournament, a four-person scramble set for Sept. 5 at the Royal Links Golf Club in Las Vegas. Read more

Bryan Lee, MD, JD, wins Vanguard Ophthalmology Society Scholar Award

Bryan S. Lee, MD, JD, a cornea, glaucoma, and refractive surgery fellow at Minnesota Eye Consultants, is the inaugural recipient of the Vanguard Ophthalmology Society Scholar Award. Read more

Haag-Streit, Reliance Medical Products name Ernest Cavin president, CEO

Ernest Cavin, MBA, DBA, has been named president and chief executive officer (CEO) of Haag-Streit USA and Reliance Medical Products, both based in Mason, OH. Read more

Sightpath expands social media efforts

Sightpath, a provider of mobile and fixed ophthalmic surgical products, has created a company blog, a Facebook page, a Twitter account, and a Vimeo channel, as well as a fortified LinkedIn profile. Read more

Check out Ophthalmology Times on Twitter and FacebookLaser, FDA, femtosecond

How Bevacizumab Monotherapy Can Help Patients with ROP

Did you miss the July 5th issues of the Ophthalmology Times eReport? In this e-newsletter we released information on Bevacizumab (Avastin, Genentech) monotherapy for zone I retinopathy of prematurity, gender difference in presbyopia assistance, a scholarship for the “most beautiful eyes” and more. Check out the articles in this issue below.

Bevacizumab monotherapy shows potential for some patients with ROP

Bevacizumab (Avastin, Genentech) monotherapy for zone I retinopathy of prematurity (ROP) might have potential for treating pre-term infants who are in phase II of the pathogenesis of ROP. Read more

Gender differences may factor into presbyopia assistance

Ophthalmologists should consider gender differences in arm length and reading distance preferences when prescribing reading glasses or bifocal lenses, according to a recent study published in Investigative Ophthalmology & Visual Science. Such factors mean that women tend to desire assistance with presbyopia symptoms earlier than men do. Read more

George Bartley to become Ophthalmology editor in January

George B. Bartley, MD, will succeed Andrew P. Schachat, MD, as editor-in-chief of Ophthalmology, the American Academy of Ophthalmology’s (AAO’s) flagship journal, in January. Dr. Schachat has served in this capacity since 2003. Read more

Scholarship to be awarded for ‘most beautiful eyes’

A $10,000 educational scholarship is up for grabs in Prevent Blindness America’s (PBA’s) 2012 Most Beautiful Eyes Contest. Read more

Vitrectomy system gains 510(k) clearance

Synergetics USA Inc. has received 510(k) marketing clearance from the FDA for its proprietary vitrectomy system (VersaVIT). Read more

Acucela receives ‘Emerging Leader’ award

Acucela Inc. has been named as a recipient of the 2012 Emerging Leaders award from the Japan-U.S. Innovation Awards. Read more

NicOx, RPS sign worldwide licensing agreement

NicOx S.A. and Rapid Pathogen Screening Inc (RPS) have entered into a licensing agreement that gives NicOx access to RPS’s point-of-care ocular diagnostic tests. Read more